Clinical considerations of lipid target and goal in dyslipidemia control

In clinical practice, physicians often use certain strategies based on guidelines or recommendations from experts. This is because in the era of evidencebased medicine, clinicians are more willing to make “evidence-based” decisions. This is also the case in the field of lipid-lowering therapy. The term “lipidlowering therapy” does not simply refer to items with abnormal values in the lipid profile, and individualized management is all the more important in the overall assessment of a patient. Thus, it is easy to conclude that doctors need a relatively authoritative assessment system to determine whether a patient requires lipidlowering therapy, as well as the intensity of therapy, the blood lipid indicators for therapy, and the expected target of therapy. The above-mentioned issues are briefly reviewed in this paper.